Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
All News
Headline News
Press Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Real Brokerage (NASDAQ:REAX) Beats Q1 EPS Estimates, Posts 32% Revenue Jump Amid Landmark RE/MAX Acquisition ↗
Via Chartmill
Tickers REAX
Which stocks are moving before the opening bell on Thursday? ↗
Via Chartmill
Tickers AAON AGL ASBP ATRA CCRN ENGN
GPGI (NYSE:GPGI) Plunges 12.7% Pre-Market After Q1 Earnings Miss ↗
Via Chartmill
Tickers GPGI
OppFi Inc (NYSE:OPFI) Q1 Earnings Beat Drives 165% Net Income Surge ↗
Via Chartmill
Topics Earnings
Tickers OPFI
Exposures Financial
Harmony Biosciences Holdings (NASDAQ:HRMY) Q1 Revenue Meets Guidance, But EPS Miss and Elevated Spending Weigh on Shares ↗
Via Chartmill
Tickers HRMY
Ironwood Pharmaceuticals (NASDAQ:IRWD) Crushes Q1 Estimates with 97% LINZESS Surge ↗
Via Chartmill
Tickers IRWD
Gibraltar Industries Inc (NASDAQ:ROCK) Q1 Earnings Beat Revenue Estimates but Miss on EPS Amid Profitability Pressure ↗
Via Chartmill
Topics Earnings
Tickers ROCK
Exposures Financial
Insmed (NASDAQ:INSM) Q1 Revenue Miss Triggers Pre-Market Slide Despite Narrower Loss ↗
Via Chartmill
Tickers INSM
Ligand Pharmaceuticals (NASDAQ:LGND) Shares Fall on Q1 Revenue and EPS Miss ↗
Via Chartmill
Tickers LGND
Nexstar Media Group (NASDAQ:NXST) Surges on Q1 Earnings Beat Driven by Record Revenue and TEGNA Acquisition ↗
Via Chartmill
Topics Earnings
Tickers NXST
Exposures Financial
Viatris (NASDAQ:VTRS) Shares Rise as Q1 Earnings Top Estimates ↗
Via Chartmill
Tickers VTRS
ARKO Corp. (NASDAQ:ARKO) Surges on Q1 Earnings Beat, Fueled by Margin Expansion and Strategic Progress ↗
Via Chartmill
Topics Earnings
Tickers ARKO
Exposures Financial
Xeris Biopharma (NASDAQ:XERS) Achieves First Profit, Beats Q1 Estimates with 95% Recorlev Surge ↗
Via Chartmill
Tickers XERS
Scholar Rock (SRRK) Q1 Loss Narrows In Line Awaits PDUFA Decision ↗
Via Chartmill
Tickers SRRK
Liberty Latin America (NASDAQ:LILA) Q1 2026 Results Miss Estimates, Unveils Preferred Stock Distribution ↗
Via Chartmill
Tickers LILA
WHF (WhiteHorse Finance Inc) Shares Dip 3% Pre-Market After Q1 Earnings and Revenue Miss ↗
Via Chartmill
Tickers WHF
Iovance Biotherapeutics (NASDAQ:IOVA) Reports Q1 Revenue Beat and Raised Guidance, Yet Stock Slips Pre-Market ↗
Via Chartmill
Tickers IOVA
Collegium Pharmaceutical (NASDAQ:COLL) Surges on Q1 Earnings Beat as JORNAY PM Revenue Jumps 36% ↗
Via Chartmill
Topics Earnings
Tickers COLL
Exposures Financial
Palvella Therapeutics (NASDAQ:PVLA) Reports Wider Q1 Loss but NDA Submission Stay on Track ↗
Via Chartmill
Tickers PVLA
ImmunityBio Inc (NASDAQ:IBRX) Q1 Revenue Beat Overshadowed by Wider Losses and Stock Decline ↗
Via Chartmill
Tickers IBRX
Evergy (NASDAQ:EVRG) Beats Q1 Estimates, Reaffirms Guidance on Rising Demand ↗
Via Chartmill
Tickers EVRG
Ispire Technology Inc (NASDAQ:ISPR) Misses Q3 Estimates as Strategic Repositioning Continues ↗
Via Chartmill
Tickers ISPR
Stoneridge (SRI) Q1 Revenue Beats Estimates, But EPS Miss Tempers Enthusiasm ↗
Via Chartmill
Tickers SRI
Amylyx Pharmaceuticals (NASDAQ:AMLX) Q1 Loss Slightly Wider Than Expected as All Eyes Turn to Q3 Avexitide Trial Data ↗
Via Chartmill
Tickers AMLX
Better Home & Finance (NASDAQ:BETR) Q1 2026 Results: Revenue and Volume Surge, but Net Loss Widens ↗
Via Chartmill
Tickers BETR
Acacia Research (NASDAQ:ACTG) Q1 Results Beat EPS Estimates Despite Sharp Revenue Decline ↗
Via Chartmill
Tickers ACTG
U.S. Energy Corp. (NASDAQ:USEG) Falls 6% After Q1 Earnings Miss ↗
Via Chartmill
Tickers USEG
Turning Point Brands (NYSE:TPB) Surges on Strong Revenue Beat and Raised Modern Oral Guidance ↗
Via Chartmill
Tickers TPB
MarketWise (NASDAQ:MKTW) Billings Surge 15% in Q1, but GAAP Revenue Miss Sends Stock Down 10% ↗
Via Chartmill
Tickers MKTW
Dime Community Bancshares (NYSE:DCOM) Meets Minervini Trend Template and High Growth Momentum Criteria ↗
Via Chartmill
Tickers DCOM
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.